Prevalence of Endocrinopathies in Turkish Children With β-Thalassemia Major: A Single-Center Study

Ayça Altincik1, Mehmet Akin

  • 1*Pediatric Enocrinology Unit, State Hospital of Denizli †Department of Pediatric Hematology, Faculty of Medicine, Pamukkale University, Denizli, Turkey.

Insights

Endocrine issues like vitamin D insufficiency and short stature are common in children with beta-thalassemia major (BTM), despite effective chelation. Regular monitoring of growth and endocrine function is crucial for improving quality of life in these patients.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Hematology

Background:

  • Chelation therapy has improved survival for patients with beta-thalassemia major (BTM).
  • Endocrine complications remain a significant challenge for BTM patients.
  • Understanding the prevalence and risk factors for endocrine issues is vital.

Purpose of the Study:

  • To determine the prevalence of endocrine complications in children with BTM.
  • To investigate the relationship between serum ferritin levels and these complications.

Main Methods:

  • Forty-five children with BTM (mean age 12.39 years) were enrolled.
  • Serum ferritin levels were measured.
  • Prevalence of endocrine complications including vitamin D insufficiency, short stature, pubertal impairment, and osteopenia was assessed.

Main Results:

  • The most common endocrine complications were vitamin D insufficiency (54.5%), short stature (42%), and pubertal impairment (25%).
  • Osteopenia was observed in 13% of patients.
  • Serum ferritin levels did not correlate with anthropometric or laboratory data.

Conclusions:

  • Endocrine complications are highly prevalent in children with BTM.
  • Monitoring growth, vitamin D status, and endocrine functions is essential for optimizing quality of life.
  • Further research may be needed to understand the specific mechanisms linking BTM and endocrine dysfunction.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Probability Laws01:49

Probability Laws

Overview
44.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
996
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.6K